AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 181 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $200,845,000 | +51.3% | 2,978,134 | +3.5% | 5.05% | +18.7% |
| Q4 2018 | $132,711,000 | -21.7% | 2,878,134 | +30.9% | 4.25% | -5.2% |
| Q3 2018 | $169,504,000 | -8.4% | 2,197,931 | 0.0% | 4.48% | -16.1% |
| Q2 2018 | $185,132,000 | -10.7% | 2,197,931 | -13.3% | 5.34% | -6.7% |
| Q1 2018 | $207,333,000 | +33.3% | 2,535,253 | -6.8% | 5.73% | +30.9% |
| Q4 2017 | $155,502,000 | -15.3% | 2,719,998 | -1.1% | 4.38% | -13.8% |
| Q3 2017 | $183,562,000 | +24.3% | 2,749,998 | -4.2% | 5.08% | +12.6% |
| Q2 2017 | $147,637,000 | -11.0% | 2,869,528 | +1.1% | 4.51% | -16.8% |
| Q1 2017 | $165,828,000 | +41.4% | 2,839,528 | +1.1% | 5.42% | +24.9% |
| Q4 2016 | $117,242,000 | -16.2% | 2,809,528 | +6.0% | 4.34% | -11.7% |
| Q3 2016 | $139,948,000 | +41.3% | 2,649,528 | +12.1% | 4.92% | +25.9% |
| Q2 2016 | $99,011,000 | +12.9% | 2,363,321 | +9.4% | 3.91% | +12.1% |
| Q1 2016 | $87,693,000 | -37.5% | 2,159,921 | 0.0% | 3.48% | -11.8% |
| Q4 2015 | $140,222,000 | -5.9% | 2,159,921 | +2.4% | 3.95% | -16.4% |
| Q3 2015 | $148,939,000 | -32.7% | 2,109,921 | +6.0% | 4.72% | -21.2% |
| Q2 2015 | $221,160,000 | +26.8% | 1,989,921 | +7.6% | 6.00% | +15.4% |
| Q1 2015 | $174,448,000 | -16.5% | 1,849,921 | -0.8% | 5.20% | -23.2% |
| Q4 2014 | $208,946,000 | +80.2% | 1,864,921 | -1.4% | 6.77% | +43.5% |
| Q3 2014 | $115,983,000 | +400.3% | 1,890,521 | +273.6% | 4.72% | +327.9% |
| Q2 2014 | $23,185,000 | – | 506,000 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |